June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 27, 2025

CGM Boosts Wound Healing, Lowers A1c: Study

Short-term CGM use improved A1c, wound healing, and reduced ED visits in diabetic foot patients, per data from ADA’s 85th Scientific Sessions.

Conexiant

June 27, 2025

Ecnoglutide Shows Strong Weight Loss in Trial

A once-weekly GLP-1 receptor agonist, ecnoglutide, led to significant and sustained weight loss in a large study of adults with overweight or obesity, with favorable safety outcomes reported at the ADA’s 85th Scientific Sessions.

Conexiant

June 27, 2025

Once-Monthly Drug Cuts Weight by 16%: Study

A once-monthly injectable GLP-1/GIP modulator demonstrated substantial weight loss in adults with obesity, with or without type 2 diabetes.

Conexiant

June 19, 2025

GLP-1 Use Associated with Less Pain, Fatigue

At the EULAR 2025 Congress, researchers reported that GLP-1 receptor agonists were linked to reduced opioid use, pain, and fatigue in fibromyalgia patients based on a large real-world analysis.

Conexiant

June 16, 2025

Updated Guidance on Antirheumatic Drug Use

New 2024 EULAR recommendations offer evidence-based guidance for the use of antirheumatic drugs during pregnancy, lactation, and conception planning in patients with rheumatic and musculoskeletal diseases.

Conexiant

February 18, 2025

Spine Symposium Presents Solutions for the Back

“It’s important that physicians be able to identify red flags and better understand the role of surgery in the treatment of common degenerative pathology of the spine,”

Baptist Health South Florida

April 29, 2025

Can Five Proteins Predict Liver Disease?

"Imagine if we could predict risk of metabolic dysfunction-associated steatotic liver disease (MASLD) years before it starts."

Conexiant

June 03, 2025

Plant Diet May Delay Myeloma Precursor Progression

First clinical trial shows high-fiber plant-based diet improves microbiome and may delay MGUS/SMM progression to multiple myeloma.

Conexiant